| Financial Year |
March 31 2023 |
| Monetary Funds |
607,362,459.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,066,000.00 |
| Accounts Receivable |
2,531,843,171.96 |
| Advances to Suppliers |
225,475,700.97 |
| Other Receivables |
58,661,235.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
162,725,019.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
468,099,097.45 |
| Other Current Assets |
545,303,011.10 |
| Total Current Assets |
4,644,473,284.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
250,819,754.18 |
| Long-term Equity Investment |
158,888,892.52 |
| Investment Properties |
-- |
| Fixed Assetes |
5,176,939,020.61 |
| Under-construction Projects |
841,933,780.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
281,398,689.86 |
| R&D expenses |
5,834.37 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
40,650,408.00 |
| Deferred Income Tax Assets |
1,295,868.31 |
| Other Non-Current Assets |
29,018,250.00 |
| Sub-Total of Non-Current Assets |
7,493,861,029.74 |
| Total Assets |
12,138,334,313.84 |
| Short-Term Loans |
1,191,130,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
261,003,235.58 |
| Accounts Payable |
2,006,085,619.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,099,805.27 |
| Taxes Payable |
46,783,319.02 |
| Interest Payable |
4,946,236.34 |
| Dividend Payable |
1,806,050.41 |
| Other payables |
81,122,857.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
861,058,057.28 |
| Other Current Liabilities |
160,338,294.84 |
| Sub-Total of Current Liabilities |
4,711,736,079.47 |
| Long-term Loans |
3,173,464,152.25 |
| Bonds Payable |
71,459,221.10 |
| Long-Term Accounts Payable |
64,956,459.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,601,622.76 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,612,399,663.82 |
| Total Liabilities |
8,324,135,743.29 |
| Paid-In Capital(Or Share Stock) |
710,509,667.00 |
| Capital Surplus |
1,789,850,812.79 |
| Surplus Reserve |
145,461,633.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,144,459,271.20 |
| Minority Stockholder's Interest |
14,326,655.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,799,871,915.19 |
| Owner's Equity（Stockholder's Equity） |
3,814,198,570.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,138,334,313.84 |
